Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-09-21

Clinical Trial Update: VaxTeen Hepatitis B Vaccine Booster Study [Phase 4]

View source ↗

Summary

This Phase 4 trial update reports the completion of a booster-dose study for the VaxTeen Hepatitis B Vaccine to prevent hepatitis B infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VaxTeen Hepatitis B Vaccine Booster (Hepatitis B vaccine)

Snippet

Sponsor: Centers for Disease Control and Prevention | Conditions: Hepatitis | Phase 4 | Status: COMPLETED